Apr 15, 2010

Institute for Advanced Biosciences, Keio University, starts a new drug developement in an All-Japan System

The Institute for Advanced Biosciences, Keio University (Masaru Tomita, Director General), has announced the start of a new drug development program in collaboration with eight national research institutes based on the “Fundamental Research Promotion Program in the Healthcare and Medical Field” of the National Institute of Biomedical Innovation (Koichi Yamanishi, Director General).

(Reference: FY2010 Projects by National Institute of Biomedical Innovation(Japanese) )